Loading clinical trials...
Loading clinical trials...
Maxigesic 325 Acute Dental Pain Study: A Double-blind, Placebo-controlled, Randomized, Parallel Group Comparison of the Effects of Maxigesic 325 Versus Acetaminophen, Ibuprofen and Placebo in Participants With Acute Dental Pain
Conditions
Interventions
Maxigesic 325
Acetaminophen
+2 more
Locations
4
United States
Premier Research
Austin, Texas, United States
Clinical Trial New Zealand
Hamilton, Waikato Region, New Zealand
Clinical Solutions Ltd.
Auckland, New Zealand
Southern Clinical Trials
Christchurch, New Zealand
Start Date
April 1, 2013
Primary Completion Date
December 1, 2014
Completion Date
January 1, 2015
Last Updated
December 6, 2018
NCT07130760
NCT07102121
NCT06760312
NCT06704113
NCT05194449
NCT00694369
Lead Sponsor
AFT Pharmaceuticals, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions